Back to the drawing board: The FACTS 001 trial, a study to test whether tenofovir gel could prevent HIV infection, did not confirm the gel’s effectiveness. While these results are disappointing, USAID is supporting the development of many other promising solutions, including vaginal rings and long-acting injectables.
In December 2012, USAID released a new strategy to address some of the world’s most challenging health and development issues through new technologies, research and evaluation. Read more >>
On June 5, 1981, the Morbidity and Mortality Weekly Report reported that five seemingly healthy young gay men were diagnosed with an infection that would typically affect only individuals with substantial damage to their immune system. As similar cases cropped up, national and international attention soared, and the scientific and public health community mobilized to […]
The results of the USAID and CAPRISA 004 trial are encouraging, and provide hope that women will soon have greater control over HIV prevention. Read more >>
Microbicides can help prevent HIV transmission in women. Read more to find out how. Read more >>
Carol is in her mid-20s and raising her young daughter on her own. With very few economic options available to her she turned to commercial sex work when she was 21 years old. Every day she puts herself at risk of HIV, other STIs, and unintended pregnancy. Because of a USAID-funded campaign, Carol knows she […]
